Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Once Daily Gastroretentive Gabapentin (Gralise) in the Treatment of Post Amputation Pain

NCT01776671 is registered in ClinicalTrials.gov with Chicago Anesthesia Pain Specialists as lead sponsor.

NCT NCT01776671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01776671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Once Daily Gastroretentive Gabapentin (Gralise) in the Treatment of Post Amputation Pain
Lead sponsor
Chicago Anesthesia Pain Specialists
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2013
Completion date
December 31, 2018
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, quality of life